|
|
||||||||
Ann Thorac Surg 1999;67:1871-1873
© 1999 The Society of Thoracic Surgeons
a Division of Cardiac Surgery, Johns Hopkins Hospital, Baltimore, Maryland, USA
Address reprint requests to Dr Baumgartner, Johns Hopkins Hospital, 600 N. Wolfe St., Blalock 618, Baltimore, MD 21287-4618
e-mail: wbaumgar{at}welchlink.welch.jhu.edu
Presented at the Aortic Surgery Symposium VI, April 30May 1, 1998, New York, NY.
| Abstract |
|---|
|
|
|---|
Results. Using a selective NMDA (glutamate) receptor antagonist (MK801) and an AMPA antagonist (NBQX), glutamate excitotoxicity in the development of HCA-induced brain injury was documented and validated. A microdialysis technique was employed to evaluate the role of nitric oxide (NO) in neuronal cell death. Arginine plus oxygen is converted to NO plus citrulline (CIT) by the action of NO synthase (nNOS). CIT recovery in the cerebrospinal fluid and from canine cortical homogenates increased during HCA and reperfusion. These studies demonstrated that neurotoxicity after HCA involves a significant and early induction of nNOS expression, and neuronal processes leading to widespread augmentation of NO production in the brain.
To further investigate the production of excitatory amino acids in the brain, we hypothesized the following scenario: HCA
glutamate,
aspartate,
glycine
intracellular Ca2+
NO + CIT. Using the same animal preparation, we demonstrated that HCA caused increased intracerebral glutamate and aspartate that persists up to 20 h post-HCA. HCA also resulted in CIT (NO) production, causing a continued and delayed neurologic injury. Confirmatory evidence of the role of NO was demonstrated by a further experiment using a specific nNOS inhibitor, 7-nitroindazole. Animals underwent 2 h of HCA, and then were evaluated both physiologically and for NO production. 7-Nitroindazole reduced CIT (NO) production by 58.4 ± 28.3%. In addition, dogs treated with this drug had superior neurologic function compared with untreated HCA controls.
Conclusions. These experiments have documented the role of glutamate excitotoxicity in neurologic injury and have implicated NO as a significant neurotoxin causing necrosis and apoptosis. Continued research into the pathophysiologic mechanisms involved in cerebral injury will eventually yield a safe and reliable neuroprotectant strategy. Specific interventional agents will include glutamate receptor antagonists and specific neuronal NO synthase inhibitors.
| Introduction |
|---|
|
|
|---|
Understanding the mechanisms of central nervous system cell death associated with HCA may provide valuable information that is generic to cerebral injury involved in all types of cardiac surgery. In addition, this injury and its potential therapeutic interventional strategies may also be relevant to spinal cord injury in major aortic surgery.
| Material and methods |
|---|
|
|
|---|
| Hypothesis |
|---|
|
|
|---|
Our research question has been: "What is the mechanism of neuronal cell injury and death in animals undergoing HCA?" Figure 1 depicts the mechanism originally proposed. We have conducted our research to validate these steps in an effort to then develop therapeutic mechanisms of intervention.
|
Glutamate receptors include the N-methyl-D-aspartate (NMDA) subtype and several non-NMDA subtypes, which are expressed in selected areas of the brain, including the hippocampus, dentate nucleus, basal ganglia, and cerebellum.
| Results |
|---|
|
|
|---|
Dogs who received MK-801 showed minimal neurologic abnormalities compared to controls [1]. Selected neuronal necrosis was the predominant lesion observed histologically: the areas affected were those in which NMDA receptors are prominent. These include the hippocampus, cerebellum, and basal ganglia. Receptor autoradiography also demonstrated preserved NMDA receptors in animals treated with MK-801.
We felt the evidence from this study validated the concept of excitotoxicity in a clinical canine model of cardiopulmonary bypass and HCA. We have also demonstrated the efficacy of a non-NMDA receptor subtype antagonist (NBQX) in preserving neuronal receptor expression and reducing neuronal necrosis compared with control animals [5].
Assessment of the neurotransmittor glutamate
Having made the observation that a specific glutamate receptor blocker (MK-801) strongly influenced the outcome of animals undergoing HCA, we wanted to document further the role of glutamate in this process. Using microdialysis techniques, intracerebral levels of excitatory amino acids were quantitatively measured. The results were the first direct evidence that HCA causes increased intracerebral glutamate and that this increase continues up to 20 hours post-HCA [6]. In addition, there was a concomitant increase in the glutamate coagonist glycine.
| Induction of nitric oxide |
|---|
|
|
|---|
Reduction of neuronal apoptosis using neuronal NOS inhibition
With the demonstration that neuronal NOS is induced with HCA, this study was designed to evaluate whether apoptosis, or programmed cell death, is a possible cause of the neurologic injury seen with HCA, and whether apoptosis is related to NO production. The purpose of this study, then, was to determine if neuronal NOS inhibition reduces neuronal apoptosis in the established canine model of HCA.
In this study, control dogs were compared with those treated with a neuronal NO inhibitor, 7-nitroindazole [8]. Dogs were killed at varying times from 8 to 72 hours after HCA. The degree of apoptosis was scored from 0 (normal) to 100 (severe injury). In vivo production of NOS activity was measured as CIT production. 7-Nitroindazole significantly suppressed CIT concentration compared with control animals (Fig 2). In addition, the quantitative apoptotic score in control dogs was significantly higher than in those dogs who received 7-nitroindazole treatment (61.1 ± 5.4 vs 19.2 ± 14.4; p < 0.001). Apoptosis occurred in a time-dependent fashion, peaking at 8 hours after HCA, and disappearing almost completely by 72 hours. In contrast, necrosis occurred at all three time points, but most prominently at 72 hours. Areas affected included the hippocampus, stria terminalis, neocortex, and entorhinal cortex. The NMDA receptor antagonist MK-801 was also tested in this model, and significantly reduced CIT production and apoptosis [9].
|
| Acknowledgments |
|---|
|
|
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
I. Dorotta, P. Kimball-Jones, and R. Applegate II Deep hypothermia and circulatory arrest in adults. Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2007; 11(1): 66 - 76. [Abstract] [PDF] |
||||
![]() |
Z. Toth, I. Gyorimolnar, H. Abraham, and A. Hevesi Cannulation and cardiopulmonary bypass produce selective brain lesions in pigs. Asian Cardiovasc Thorac Ann, August 1, 2006; 14(4): 273 - 278. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Barreiro, J. A. Williams, T. P. Fitton, M. S. Lange, M. E. Blue, L. Kratz, P. B. Barker, M. Degaonkar, V. L. Gott, J. C. Troncoso, et al. Noninvasive Assessment of Brain Injury in a Canine Model of Hypothermic Circulatory Arrest Using Magnetic Resonance Spectroscopy. Ann. Thorac. Surg., May 1, 2006; 81(5): 1593 - 1598. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. G. Ananiadou, G. E. Drossos, K. N. Bibou, G. M. Palatianos, and E. O. Johnson Acute regional neuronal injury following hypothermic circulatory arrest in a porcine model Interactive CardioVascular and Thoracic Surgery, December 1, 2005; 4(6): 597 - 601. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Amir, C. Ramamoorthy, R. K. Riemer, V. M. Reddy, and F. L. Hanley Neonatal Brain Protection and Deep Hypothermic Circulatory Arrest: Pathophysiology of Ischemic Neuronal Injury and Protective Strategies Ann. Thorac. Surg., November 1, 2005; 80(5): 1955 - 1964. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Strauch, D. Spielvogel, P. L. Haldenwang, N. Zhang, D. Weisz, C. A. Bodian, N. A. Tatton, and R. B. Griepp Cooling to 10{degrees}C and treatment with Cyclosporine A improve cerebral recovery following prolonged hypothermic circulatory arrest in a chronic porcine model Eur. J. Cardiothorac. Surg., January 1, 2005; 27(1): 74 - 80. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Khoynezhad, Z. Jalali, and A. J. Tortolani Apoptosis: Pathophysiology and therapeutic implications for the cardiac surgeon Ann. Thorac. Surg., September 1, 2004; 78(3): 1109 - 1118. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Scallan Cerebral injury during paediatric heart surgery: perfusion issues Perfusion, July 1, 2004; 19(4): 221 - 228. [Abstract] [PDF] |
||||
![]() |
J Mand'ak, P Zivny, V Lonsky, V Palicka, D Kakrdova, M Marsikova, P Kunes, and J Kubicek Changes in metabolism and blood flow in peripheral tissue (skeletal muscle) during cardiac surgery with cardiopulmonary bypass: the biochemical microdialysis study Perfusion, January 1, 2004; 19(1): 53 - 63. [Abstract] [PDF] |
||||
![]() |
C. Hagl, N. Khaladj, M. Karck, K. Kallenbach, R. Leyh, M. Winterhalter, and A. Haverich Hypothermic circulatory arrest during ascending and aortic arch surgery: the theoretical impact of different cerebral perfusion techniques and other methods of cerebral protection Eur. J. Cardiothorac. Surg., September 1, 2003; 24(3): 371 - 378. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Valen The basic biology of apoptosis and its implications for cardiac function and viability Ann. Thorac. Surg., February 1, 2003; 75(2): S656 - 660. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ueno, S. Takamoto, T. Miyairi, T. Morota, K. Shibata, A. Murakami, and Y. Kotsuka Cerebral Metabolism of Nitric Oxide During Retrograde Cerebral Perfusion Asian Cardiovasc Thorac Ann, September 1, 2002; 10(3): 223 - 227. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Hagl, N. A. Tatton, N. Khaladj, N. Zhang, S. Nandor, S. Insolia, D. J. Weisz, D. Spielvogel, and R. B. Griepp Involvement of apoptosis in neurological injury after hypothermic circulatory arrest: a new target for therapeutic intervention? Ann. Thorac. Surg., November 1, 2001; 72(5): 1457 - 1464. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Hagl, N. A. Tatton, D. J. Weisz, N. Zhang, D. Spielvogel, H. H. Shiang, C. A. Bodian, and R. B. Griepp Cyclosporine A as a potential neuroprotective agent: a study of prolonged hypothermic circulatory arrest in a chronic porcine model Eur. J. Cardiothorac. Surg., June 1, 2001; 19(6): 756 - 764. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Ehrlich, J. McCullough, D. Wolfe, N. Zhang, H. Shiang, D. Weisz, C. Bodian, and R. B. Griepp Cerebral effects of cold reperfusion after hypothermic circulatory arrest J. Thorac. Cardiovasc. Surg., May 1, 2001; 121(5): 923 - 931. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Anttila, J. Rimpilainen, M. Pokela, K. Kiviluoma, M. Makiranta, V. Jantti, V. Vainionpaa, J. Hirvonen, and T. Juvonen Lamotrigine improves cerebral outcome after hypothermic circulatory arrest: A study in a chronic porcine model J. Thorac. Cardiovasc. Surg., August 1, 2000; 120(2): 247 - 255. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |